Zachary Hargreaves
Angel Investor
Berkeley, United States
Zachary Hargreaves is a Series A investor in Berkeley focused on Health Care and Software. Zachary Hargreaves is the Chief Technology Officer and Co-Founder of Vires Aeronautics.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Zachary Hargreaves invests in
Stages Zachary Hargreaves invests in
Countries Zachary Hargreaves invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series A
- $7.5M–$55M
- Series B
- $12M–$31M
Investment Focus
Industry
- Health Care 5 (38%)
- Software 4 (31%)
- Apps 3 (23%)
- Wellness 3 (23%)
- Therapeutics 3 (23%)
Stage
- Series A 7 (54%)
- Series B 5 (38%)
- Series C 1 (8%)
Country
- United States 8 (62%)
- United Kingdom 2 (15%)
- India 1 (8%)
- Norway 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease. | $55M / Series A / Dec 19, 2023 | ||
| Savvy Wealth is a technology-enabled wealth management firm that provides a digital-first platform for financial advisors centered around optimizing human financial advice. With this platform, financial advisors utilize its purpose-built, integrated technology platform to help build organic growth with enhanced software and sales and marketingautomation. | $11M / Series A / Nov 10, 2022 | ||
| Jar is an investment tech startup that allows users to save money by taking spare change from online transactions and investing it in digital gold automatically which can be redeemed anytime or withdrawn easily through UPI. The company was co-founded in 2021 by Nishchay AG and Misbah Ashraf and is based in Bangalore, Karnataka. | $22.6M / Series B / Aug 18, 2022 | ||
| SmithRx is a pharmacy benefits partner built on a modern technology platform that creates new levels of flexibility, efficiency, and customer satisfaction. It’s a new path forward that aligns incentives and harnesses data analytics to deliver an exceptional pharmacy benefit product.A San Francisco-based technology company, SmithRx was founded in2016 to create a cost-competitive PBM that offers clients a proven pass-through model, a single technology platform, concierge-level service, and strong drug cost, rebate, and service level guarantees. The in-house team brings together experience from healthcare companies including Anthem, Collective Health, and Castlight Health, as well as a broader set of technology leaders including Facebook, LinkedIn, Glassdoor, and Docker. Front-line clinicians guide plan execution and member support.Named after a smith, a craftsman, or someone who is precise about their trade. SmithRx embodies these characteristics and brings precision to the pharmacy benefits industry by leveraging technology and data to forge the product of the future. | $27.2M / Series B / Mar 10, 2022 | ||
| Jar is an investment tech startup that allows users to save money by taking spare change from online transactions and investing it in digital gold automatically which can be redeemed anytime or withdrawn easily through UPI. The company was co-founded in 2021 by Nishchay AG and Misbah Ashraf and is based in Bangalore, Karnataka. | $32M / Series A / Feb 03, 2022 | ||
| Modern Health is a mental well-being platform for innovative companies offering therapy, coaching, and self-guided courses all in one app. The platform combines the WHO well-being assessment, self-service wellness kits, a network of certified coaches, and licensed therapists available in 35 languages all available in a seamless app. It empowersemployers to charge in acknowledging that mental health is just as important as physical health, destigmatizing the conversation, and increasing the accessibility of mental health services for all. | $31M / Series B / Jan 15, 2020 | ||
| Flo Health is a developer of Flo, a fast-growing AI-driven women’s health product that supports girls and women at every stage of their reproductive cycle (start of menstruation, cycle prediction, preparation for conception, pregnancy, early motherhood, and menopause).Flo prioritizes safety and keeps a sharp focus on being the most trusteddigital source for women's health information. It intensively uses Data Science and AI to deliver the most personalized content and services available. Flo is currently available in 20 languages on iOS and Android. 60% of users are located in the US and Europe.At the end of 2019, Flo became the most popular app in the Health&Fitness category on the AppStore. | $7.5M / Series A / May 08, 2019 | ||
| Flo Health develops a women’s health app that provides access to cycle tracking, health insights, and a private community. Flo supports women during their entire reproductive lives and provides curated cycle and ovulation tracking, personalized health insights, expert tips, and a fully closed community for women to share their questions andconcerns. Flo prioritizes safety and keeps a sharp focus on being the most trusted digital source for women's health information. The Flo Health app is available in more than 20 languages on iOS and Android. For more information, please visit https://flo.health. | $7.5M / Series A / May 08, 2019 | ||
| Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs. Its vision is to make sustainable energy consumption simple and affordable for all households. Tibber's mission is to reduce the residential electricity consumption for European households by 20 %. Founded in Norway andSweden in 2016, the company has expanded its offer to Sweden and Germany where it powers hundreds of thousands of homes. Tibber replaces traditional utilities with smart technology, supplying its customers with renewable energy at fair and transparent prices. In addition, its app provides real-time analytics into energy usage, and pairs with a variety of smart home devices to reduce electricity consumption at home. The company sells tech-gadgets in their online store and recently was licensed to balance the main power grid in Sweden with EVs. | $12M / Series A / Mar 19, 2019 | ||
| Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platformvertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs.By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology.The company was founded in 2012 and is based in Redwood City, California. | $110M / Series C / Oct 23, 2018 | ||
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Zachary Hargreaves invest in?
Zachary Hargreaves invests primarily in Health Care, Software and Apps startups, most often at Series A and Series B stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Zachary Hargreaves's check size?
Zachary Hargreaves typically joins rounds of $7.5M–$55M at Series A and $12M–$31M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Zachary Hargreaves participates in.
How do I contact Zachary Hargreaves?
Public channels for Zachary Hargreaves include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Zachary Hargreaves last invest?
The most recent investment recorded for Zachary Hargreaves closed in Dec 2023. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
